Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia nigra in the rat

Neuroscience

Volumn 109, Issue 1, 2002, Pages 89-99

  Mitchell, I J ^a   Cooper, A C ^a   Griffiths, M R ^a   Cooper, A J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Caudate; Dyskinesia; Excitotoxic; Free radical; Neuroleptic; Oxidative stress

Indexed keywords

GLUTAMIC ACID; HALOPERIDOL;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CELL DAMAGE; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; GABAERGIC SYSTEM; MALE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TRANSPORT; PUTAMEN; RAT; SUBSTANTIA NIGRA; TARDIVE DYSKINESIA;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD147; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; APOPTOSIS; AVIAN PROTEINS; BEHAVIOR, ANIMAL; BLOOD PROTEINS; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; HALOPERIDOL; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MEMBRANE GLYCOPROTEINS; NERVE DEGENERATION; NEURAL PATHWAYS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE;

EID: 0037126991     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00455-9     Document Type: Article

References (57)

1. Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP
2. The functional anatomy of basal ganglia disorders
3. Parallel organisation of functionally segregated circuits linking basal ganglia and cortex
4. 11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: No evidence for altered dopamine D-2 receptor binding
5. Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia
6. The thorny problem of what dopamine does in psychiatric disease
7. Tardive dyskinesia: Etiological and therapeutic aspects
8. Haloperidol-induced cell death and protection with vitamin E in vitro
9. Free radicals and the pathobiology of brain dopamine systems
10. Chronic neuroleptic treatment: D-2 dopamine receptor supersensitivity and striatal glutamatergic transmission
11. Localisation of gold in biological tissues. A photochemical method for light and electron microscopy
12. Excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia
13. Treatment of tardive dyskinesia
14. Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine
15. Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia
16. The cells of origin of nigrotectal, nigrothalamic and nigrostriatal projections in the rat
17. Neurobiological substrates of tardive dyskinesia: The GABA hypothesis
18. D-1 and D-2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
19. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis
20. Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: The roles of glutamate, dopamine, acetylcholine and corticosteroids
21. An animal-model for coexisting tardive dyskinesia and tardive parkinsonism. A glutamate hypothesis for tardive dyskinesia
22. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis
23. The neuropathological effects of antipsychotic drugs
24. The in vivo time course for elimination of adrenalectomy induced apoptotic profiles from the granule cell layer of the rat hippocampus
25. Dogma disputed: Is tardive dyskinesia due to postsynaptic dopamine receptor super-sensitivity
26. Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats
27. Persistence of haloperidol in human brain tissue
28. Microglial and macrophage reactions mark progressive changes and define the penumbra area in the rat neocortex and striatum after transient middle cerebral artery occlusion
29. Chronic neuroleptic effects on spatial reversal-learning in monkeys
30. Neuroleptic induced striatal damage in rats: A study of antioxidant treatment using accelerometric and immunocytochemical methods
31. Haloperidol competitively inhibits the binding of (+)[H-3]SKF-10, 047 to sigma sites
32. Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic induced dyskinesias
33. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism
34. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyirdine (MPTP)
35. Selective vulnerability of striatopallidal neurons
36. Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: A neural substrate for psychosis?
37. Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the cebus monkey
38. Common neural mechanisms in experimental chorea and hemiballismus in the monkey. Evidence from 2-deoxyglucose autoradiography
39. The role of the subthalamic nucleus in experimental chorea: Evidence from 2-deoxyglucose metabolic studies and horseradish peroxidase tracing studies
40. Glutamate-induced apoptosis results in a loss of striatal neurons in the Parkinsonian rat
41. Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid
42. Topographic distribution and collateral projections of the two major populations of nigrothalamic neurons. A retrograde labeling study in the rat
43. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: Behavioural and immunohistochemical studies
44. Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease
45. Induction of NF-κB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: Suppression of NF-κB and neuroprotection by antioxidants
46. Ultrastructural correlates of haloperidol induced oral dyskinesias in rat striatum
47. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: In vivo microdialysis and in vitro mitochondrial studies
48. Induction of reactive oxygen species in neurons by haloperidol
49. Prevention of transneuronal degeneration of neurons in the substantia nigra reticulata by ablation of the subthalamic nucleus
50. Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum
51. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia
52. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes
53. On the mechanism of neuroleptic induced increase in striatal dopamine release: Brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals
54. Effects of haloperidol metabolites on neurotransmitter uptake and release: Possible role in neurotoxicity and tardive dyskinesia
55. In vivo analysis of hydrogen peroxide and lipid radicals in the striatum of rats under long-term administration of a neuroleptic
56. Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge